Navigation Links
Cetuximab Helps Treat Colorectal Cancer
Date:11/25/2009

Drug plus chemo boosts surgery success for patients with liver lesions, researchers find

WEDNESDAY, Nov. 25 (HealthDay News) -- Adding the drug cetuximab to neoadjuvant chemotherapy can shrink tumors and boost the odds of successful surgery in colorectal cancer patients with inoperable metastatic liver lesions, new research suggests.

Tumors spread to other parts of the body in more than half of patients with colorectal cancer. Most commonly, the cancer spreads to the liver. Removing the tumors in the liver can cure patients, but about 80 percent have inoperable disease and a poor prognosis when they see doctors, the researchers explain in the Nov. 24 online edition of The Lancet Oncology.

Previous research suggests that neoadjuvant treatment with irinotecan- or oxaliplatin-based chemotherapy can make surgery more likely to succeed. The new study aimed to see if addition of the drug cetuximab, also known as Erbitux, would help patients even more.

The study authors, Gunnar Folprecht, from University Hospital Carl Gustav Carus in Dresden, Germany, and colleagues from Germany and Austria found that treatment with cetuximab boosted the proportion of tumors that could be treated with surgery. The treatment, in general, didn't have serious side effects.

"Our data suggest that treatment with cetuximab and chemotherapy results in high confirmed tumor response rates ... leading to ... increased respectability," Folprecht and colleagues wrote. "In the light of recent studies in metastatic colorectal cancer, the value of further treatment intensification will be investigated."

More information

For more about colorectal cancer, visit the U.S. National Cancer Institute.



-- Randy Dotinga



SOURCE: The Lancet Oncology, news release, Nov. 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cost-effectiveness of cetuximab in metastatic colorectal cancer
2. Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy
3. ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings
4. Scientists find molecular trigger that helps prevent aging and disease
5. Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey
6. Whats for Dinner? Brain Chemical Helps People Decide
7. Acceptance of Chronic Illness Helps People Move On
8. Avizents New TeamCOMP Approach Helps Ensure Lower Workers Comp Costs and Faster Claims Resolution
9. Cataract surgery helps AMD patients; steroid improves DME; online eye health forum
10. Adding Chemo Helps Head, Neck Cancer Patients
11. Light Touch Helps Grip of MS Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Greifensee, Switzerland (PRWEB) , ... April 24, 2017 ... ... process steps to become familiar. This makes it difficult for lab operators and ... a systematic methodology to help them identify wasteful or unnecessary actions. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study ... decade, student well-being has seriously declined. "When disenfranchised youth from the heart of ... Islamic State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... 2017 , ... Miami Periodontist and Dental Implant ... Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in Miami Beach ... Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This annual symposium ...
(Date:4/24/2017)... WA (PRWEB) , ... April 24, 2017 , ... ... leading lifestyle brands, work wear distributors and International relief organizations across the globe ... The company also offers lifestyle and work wear collections via insectshield.com . ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: